Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Frontiers in Neurology|August 23, 2023
Case report: A 33 years-old alcoholic male with diarrhea and progressive muscle weakness mimicking Guillain-Barré syndromeAnja M Rudolph, Sofia Doubrovinskaia, Johannes Knabbe, et al.Neurology|August 5, 2024
Clinical Presentation, Management, and Outcome in Neurolymphomatosis: A Systematic ReviewLeon D Kaulen, Thomas Hielscher, Sofia Doubrovinskaia, et al.Journal of Neuro-Oncology|August 8, 2024
Factors influencing timely diagnosis in neurolymphomatosisSofia Doubrovinskaia, Antonia Egert, Philipp Karschnia, et al.European Journal of Neurology|October 19, 2022
Neurological autoimmune diseases following vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A follow-up studySofia Doubrovinskaia, Christoph M Mooshage, Corinna Seliger, et al.European Journal of Neurology|October 20, 2021
Neurological autoimmune diseases following vaccinations against SARS-CoV-2: a case seriesLeon D Kaulen, Sofia Doubrovinskaia, Christoph Mooshage, et al.Neuro-Oncology|November 22, 2024
Distinct epigenetic and transcriptional profiles of Epstein-Barr virus-positive and negative primary CNS lymphomasLing Hai, Dennis Friedel, Felix Hinz, et al.Acta Neuropathologica|July 26, 2023
Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomasLeon D Kaulen, Evgeniya Denisova, Felix Hinz, et al.American Journal of Hematology|October 23, 2024
Toxicities and outcome after CD19-directed chimeric antigen receptor T-cell therapy for secondary neurolymphomatosisLeon D Kaulen, Philipp Karschnia, Sofia Doubrovinskaia, et al.Journal of Hematology & Oncology|January 14, 2026
Patterns, risk factors and management of CD19-directed chimeric antigen receptor T-cell therapy failure in CNS lymphomaLeon D Kaulen, Philipp Karschnia, Sofia Doubrovinskaia, et al.Blood|July 15, 2025
Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell TherapyLeon D Kaulen, Maria Martinez-Lage, Jeremy S Abramson, et al.Pageof 2